Effector and memory T-cell differentiation: Implications for vaccine development

Nature Reviews Immunology

Volumn 2, Issue 4, 2002, Pages 251-262

  Kaech, Susan M ^a   Wherry, E John ^a   Ahmed, Rafi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; PERFORIN; TUMOR NECROSIS FACTOR; VACCINE;

CELL LINEAGE; CELL MIGRATION; CELLULAR IMMUNITY; CLONAL EXPANSION; CLONOGENESIS; DRUG DESIGN; EFFECTOR CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MODEL; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VACCINE PRODUCTION; ANIMAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CYTOLOGY; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; HUMANS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES; VACCINES;

EID: 0036550559     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri778     Document Type: Review

References (136)

1. + T-cell memory determined by clonal burst size. Nature 369, 652-654 (1994).
2. Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177-187 (1998).
3. Busch, D. H., Pilip, I. M., Vijh, S. & Pamer, E. G. Coordinate regulation of complex T-cell populations responding to bacterial infection. Immunity 8, 353-362 (1998).
4. Bousso, P., Levraud, J. P., Kourilsky, P. & Abastado, J. P. The composition of a primary T-cell response is largely determined by the timing of recruitment of individual T-cell clones. J. Exp. Med. 189, 1591-1600 (1999).
5. Whitmire, J. K., Asano, M. S. Murali-Krishna, K., Suresh, M. & Ahmed, R. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection. J. Virol. 72, 8281-8288 (1998).
6. Agarwal, S. & Rao, A. Modulation of chromatin structure regulates cytokine gene expression during T-cell differentiation. Immunity 9, 765-775 (1998).
7. + T cells during viral infection. J. Immunol. 166, 795-799 (2001).
8. + T cells have immediate cytotoxic activity, whereas memory T cells require 12-24 hours of antigenic stimulation for this activity to be reacquired.
9. + T cells have distinct functional properties and that when stimulated with antigen, memory T cells can proliferate and express IFN-γ, IL-2 and perforin faster than naive T cells.
10. Teague, T. K. et al. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc. Natl Acad. Sci. USA 96, 12691-12696 (1999).
11. Yang, Y., Chang, J. F., Parnes, J. R. & Fathman, C. G. T-cell receptor (TCR) engagement leads to activation-induced splicing of tumor necrosis factor (TNF) nuclear pre-mRNA. J. Exp. Med. 188, 247-254 (1998).
12. + cells is antigen independent. J. Immunol. 165, 5387-5391 (2000).
13. + T cells. Nature 401, 76-79 (1999).
14. + T cells continued to divide and differentiate in the absence of further antigenic stimulation, which suggested that activated T cells are developmentally programmed to clonally expand and differentiate into effector cells.
15. Moser, B. & Loetscher, P. Lymphocyte traffic control by chemokines. Nature Immunol. 2, 123-128 (2001).
16. Masopust, D., Vezys, V., Marzo, A. L. & Lefrancois, L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291, 2413-2417 (2001).
17. Reinhardt, R. L., Khoruts, A., Merica, R., Zell, T. & Jenkins, M. K. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410, 101-105 (2001).
18. Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712 (1999). This study shows that different subsets of memory T cells exist and can be distinguished on the basis of their expression of the lymph-node-homing molecules CCR7 and L-selectin.
19. Weninger, W., Crowley, M. A., Manjunath, N. & von Andrian, U. H. Migratory properties of naive, effector, and memory CD8(+) T cells. J. Exp. Med. 194, 953-966 (2001).
20. + T-cell memory. Nature Med. 7, 913-919 (2001).
21. + T cells in vivo by IL-15. Immunity 8, 591-599 (1998).
22. - memory T cells by opposing cytokines. Science 288, 675-678 (2000).
23. Schluns, K. S., Kieper, W. C., Jameson, S. C. & Lefrancois, L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nature Immunol. 1, 426-432 (2000).
24. Ahmed, R. & Gray, D. Immunological memory and protective immunity: understanding their relation. Science 272, 54-60 (1996).
25. Shahinian, A. et al. Differential T-cell costimulatory requirements in CD28-deficient mice. Science 261, 609-612 (1993).
26. + T-cell responses were unaffected.
27. + T-cell response was severely reduced.
28. + T-cell responses were greatly reduced.
29. Gravestein, L. A., Nieland, J. D., Kruisbeek, A. M. & Borst, J. Novel mAbs reveal potent co-stimulatory activity of murine CD27. Int. Immunol. 7, 551-557 (1995).
30. + CTL response. J. Exp. Med. 183, 2129-2142 (1996).
31. Chen, A. I. et al. OX40-ligand has a critical costimulatory role in dendritic cell:T-cell interactions. Immunity 11, 689-698 (1999).
32. Gramaglia, I., Weinberg, A. D., Lemon, M. & Croft, M. OX40 ligand: a potent costimulatory molecule for sustaining primary CD4 T-cell responses. J. Immunol. 161, 6510-6517 (1998).
33. Tuosto, L. & Acuto, O. CD28 affects the earliest signaling events generated by TCR engagement. Eur. J. Immunol. 28, 2131-2142 (1998).
34. Liu, Y., Wenger R. H., Zhao, M. & Nielsen, P. J. Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J. Exp. Med. 185, 251-262 (1997).
35. Kundig, T. M. et al. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5, 41-52 (1996).
36. - effector T-cell responses. J. Immunol. 164, 3689-3697 (2000).
37. Suresh, M. et al. Role of CD28-B7 interactions in generation and maintenance of CD8 T-cell memory. J. Immunol. 167, 5565-5573 (2001).
38. Sepulveda, H., Cerwenka, A., Morgan, T. & Dutton, R. W. CD28, IL-2-independent costimulatory pathways for CD8 T-lmphocyte activation J. Immunol. 163, 1133-1142 (1999).
39. - T-cell activation. Int. Immunol. 10, 619-630 (1998).
40. Szabo, S. J. et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295, 338-342 (2002).
41. + T cells required at least six hours of antigenic stimulation by professional APCs to commit to proliferation in vitro. In the absence of co-stimulation, >20 hours were required. Effector cells could commit to proliferation after only one hour of stimulation, and if stimulation was prolonged, the effector cells would die.
42. Jelley-Gibbs, D. M., Lepak, N. M., Yen, M. & Swain, S. L. Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation. J. Immunol. 165, 5017-5026 (2000).
43. Gett, A. V. & Hodgkin, P. D. A cellular calculus for signal Integration by T cells. Nature Immunol. 1, 239-244 (2000).
44. + T cells could commit to dividing at least 7-10 times and differentiating into CTLs after only two hours of stimulation in vitro.
45. + T cells were still generated.
46. Wong, P. & Pamer E. G. Cutting edge: antigen-independent CD8 T cell proliferation J. Immunol. 166, 5864-5868 (2001).
47. Tan, J. T. et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl Acad. Sci. USA 98, 8732-8737 (2001).
48. Murali-Krishna, K. & Ahmed, R. Cutting edge: naive T cells masquerading as memory cells. J. Immunol. 165, 1733-1737 (2000).
49. + T cells in vivo.
50. Whitmire, J. K., Slifka, M. K., Grewal, I. S., Flavell, R. A. & Ahmed, R. CD40-ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J. Virol. 70, 8375-8381 (1996).
51. Busch, D. H. & Pamer, E. G. T-lymphocyte dynamics during Listeria monocytogenes infection. Immunol. Lett. 65, 93-98 (1999).
52. Wherry, E. J., Puorro, K. A., Porgador, A. & Eisenlohr, L. C. The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained. J. Immunol. 163, 3735-3745 (1999).
53. Kedl, R. M. et al. T cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 192, 1105-1113 (2000).
54. Ludewig, B. et al. Dendritic cells efficiently induce protective antiviral immunity. J. Virol. 72, 3812-3818 (1998).
55. - cytotoxic T-cell responses during chronic viral infection. J. Virol. 88, 8056-8063 (1994).
56. + T-cell responses.
57. Moskophidis, D., Lechner, F., Pircher, H. & Zinkernagel, R. M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362, 758-761 (1993).
58. Zhou, S., Ou, R., Huang, L. & Moskophidis, D. Critical role for perforin-, Fas/FasL- and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection. J. Virol. 76, 829-840 (2002).
59. Lauvau, G. et al. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294, 1735-1739 (2001).
60. Manjunath, N. et al. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 108, 871-878 (2001).
61. Vijh, S. & Pamer, E. G. Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. J. Immunol. 158, 3366-3371 (1997).
62. Iezzi, G., Scotet, E., Scheidegger, D. & Lanzavecchia, A. The interplay between the duration of TCR and cytokine signaling determines T-cell polarization. Eur. J. Immunol. 29, 4092-4101 (1999).
63. H2 and nonpolarized T cells. Nature Immunol. 1, 311-316 (2000).
64. Iezzi, G. Scheidegger, D. & Lanzavecchia, A. Migration and function of antigen-primed nonpolarized T lymphocytes in vivo. J. Exp. Med. 193, 987-993 (2001).
65. Bird, J. J. et al. Helper T-cell differentiation is controlled by the cell cycle. Immunity 9, 229-237 (1998).
66. Gett, A. V. & Hodgkin, P. D. Cell division regulates the T-cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc. Natl Acad. Sci. USA 95, 9486-9493 (1998).
67. Grogan, J. L. et al. Early transcription and silencing of cytokine genes underlie polarization of T-helper-cell subsets. Immunity 14, 205-215 (2001).
68. Bajenoff, M., Wuriz, O. & Guerder, S. Repeated antigen exposure is necessary for the differentiation, but not the initial proliferation, of naive CD4(+) T cells. J. Immunol. 168, 1723-1729 (2002).
69. Chao, C. C., Jensen, R. & Dailey, M. O. Mechanisms of L-selectin regulation by activated T cells. J. Immunol. 159, 1686-1694 (1997).
70. Oehen, S. & Brduscha-Riem, K. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161, 5338-5346 (1998).
71. Campbell, D. J., Kim, C. H. & Butcher, E. C. Separable effector T-cell populations specialized for B-cell help or tissue inflammation. Nature Immunol. 2, 876-881 (2001).
72. Campbell, D. J. & Butcher, E. C. Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J. Exp. Med. 195, 135-141 (2002).
73. Jacob, J. & Baltimore, D. Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399, 593-597 (1999).
74. Opferman, J. T., Ober, B. T. & Ashton-Rickardt, P. G. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 283, 1745-1748 (1999).
75. Hu, H. et al CD4(+) T-cell effectors can become memory cells with high efficiency and without further division. Nature Immunol. 2, 705-710 (2001).
76. Champagne, P. et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410, 106-111 (2001).
77. Vella, A. T., Dow, S., Potter, T. A., Kappler, J. & Marrack, P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl Acad. Sci. USA 95, 3810-3815 (1998).
78. Marrack, P., Kappler, J. & Mitchell, T. Type I interferons keep activated T cells alive. J. Exp. Med. 189, 521-530 (1999).
79. Qin, J. Z. et al. Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood 98, 2778-2783 (2001).
80. Sprent, J., Zhang, X., Sun, S. & Tough, D. T-cell proliferation in vivo and the role of cytokines. Phil. Trans. R. Soc. Lond. B Biol. Sci. 355, 317-322 (2000).
81. + patients: a randomized controlled trial. HIV Clin. Trials 1, 1-15 (2000).
82. Barouch, D. H. et al. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL2/Ig plasmid administration in rhesus monkeys. Proc. Natl. Acad. Sci. USA 97, 4192-4197 (2000).
83. Ahlers, J. D., Dunlop, N., Alling, D. W., Nara, P. L. & Berzofsky, J. A. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-α synergize with IL-12 to enhance induction of cytotoxic T lymphocytes. J. Immunol. 158, 3947-3958 (1997).
84. Kuroda, K. et al. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen. J. Immunol. 157, 1422-1431 (1996).
85. Shimizu, K., Fields, R. C., Giedlin, M. & Mule, J. J. Systemic administration of interleukin-2 enhances the therapeutic efficacy of dendritic-cell-based tumor vaccines. Proc. Natl. Acad. Sci. USA 96, 2268-2273 (1999).
86. Kang, B. Y. et al. Antigen-specific cytotoxicity and cell number of adoptively transferred T cells are efficiently maintained in vivo by re-stimulation with an antigen/interleukin-2 fusion protein. Int. J. Cancer 82, 569-573 (1999).
87. Yajima, T. et al. Overexpression of IL-15 in vivo increases antigen-driven memory CD8(+) T cells following a microbe exposure. J. Immunol. 168, 1198-1203 (2002).
88. + T-cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii. J. Immunol. 163, 4503-4509 (1999).
89. Maeurer, M. J. et al. Interleukin-7 of interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice. Infect. Immun. 68, 2962-2970 (2000).
90. Busch, D. H., Kerksiek, K. M. & Pamer, E. G. Differing roles of inflammation and antigen in T-cell proliferation and memory generation. J. Immunol. 164, 4063-4070 (2000).
91. Whitmire, J. K. & Ahmed, R. Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T-cell responses. Curr. Opin. Immunol. 12, 448-455 (2000).
92. + T cells after antigen challenge in the absence of Fas (CD95). Eur. J. Immunol. 26, 2903-2910 (1996).
93. Nguyen, L. T. et al. TNF receptor 1 (TNFR1) and CD95 are not required for T-cell deletion after virus infection but contribute to peptide-induced deletion under limited conditions. Eur. J. Immunol. 30, 683-688 (2000).
94. Reich, A., Korner, H., Sedgwick, J. D. & Pircher, H. Immune down-regulation and peripheral deletion of CD8 T cells does not require TNF-receptor-ligand interactions nor CD95 (Fas, APO-1). Eur. J. Immunol. 30, 678-682 (2000).
95. Suzuki, A. et al. T-cell-specific loss of PTEN leads to defects in central and peripheral tolerance. Immunity 14, 523-534 (2001).
96. + T-cell homeostasis by perforin and interferon-γ. Science 290, 1354-1358 (2000).
97. + T cells by perforin. Eur. J. Immunol. 29, 3262-3272 (1999).
98. Matloubian, M. et al. A role for perforin in downregulating T-cell responses during chronic viral infection. J. Virol. 73, 2527-2536 (1999).
99. Opferman, J. T., Ober, B. T., Narayanan, R. & Ashton-Rickardt, P. G. Suicide induced by cytolytic activity controls the differentiation of memory CD8(+) T lymphocytes. Int. Immunol. 13, 411-419 (2001).
100. Lee, P. P. et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nature Med. 5, 677-685 (1999).
101. Appay, V. et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192, 63-75 (2000).
102. Kostense, S. et al. High viral burden in the presence of major HIV-specific CD8(+) T-cell expansions: evidence for impaired CTL effector function. Eur. J. Immunol. 31, 677-686 (2001).
103. Lechner, F. et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191, 1499-1512 (2000).
104. + T cells in vivo: multiple thresholds in response to a constant level of antigen presentation. J. Immunol. 167, 2030-2039 (2001).
105. McKay, P. F. et al. Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys. J. Immunol. 168, 332-337 (2002).
106. Edwards, B. H. et al. Magnitude of functional CD8(+) T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J. Virol. 76, 2298-2305 (2002).
107. Betts, M. R. et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75, 11983-11991 (2001).
108. Herrmann, J. E. et al. Protection against rotavirus infections by DNA vaccination. J. Infect. Dis. 174, S93-S97 (1996).
109. Amara, R. R. et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292, 69-74 (2001).
110. Savage, P. A., Boniface, J. J. & Davis, M. M. A kinetic basis for T-cell receptor repertoire selection during an immune response. Immunity 10, 485-492 (1999).
111. Kedl, R. M., Schaefer, B. C., Kappler, J. W. & Marrack, P. T cells down-modulate peptide-MHC complexes on APCs in vivo. Nature Immunol. 3, 27-32 (2002).
112. + T cells during an acute virus infection. Immunity 8, 167-175 (1998).
113. Busch, D. H. & Pamer, E. G. T-cell affinity maturation by selective expansion during infection. J. Exp. Med. 189, 701-710 (1999).
114. Berzofsky, J., Ahlers, J. & Belyakov, I. Strategies for designing and optimizing new generation vaccines. Nature Rev. Immunol. 1, 209-219 (2001).
115. + T-cell memory. Immunol. Rev. 150, 23-44 (1996).
116. Arbones, M. L. et al. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1, 247-260 (1994).
117. Warnock, R. A., Askan, S., Butcher, E. C. & von Andrian, U. H. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J. Exp. Med. 187, 205-216 (1998).
118. Campbell, J. J. et al. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7. J. Cell. Biol. 141, 1053-1059 (1998).
119. + T cells. Proc. Natl Acad. Sci. USA 98, 6313-6318 (2001).
120. Watt, F. M. & Hogan, B. L. Out of Eden: stem cells and their niches. Science 287, 1427-1430 (2000).
121. + T cells during acute Epstein-Barr virus infection. Blood 97, 700-707 (2001).
122. Weng, N. P., Hathcock, K. S. & Hodes, R. J. Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity 9, 151-157 (1998).
123. Hathcock, K. S., Weng, N. P., Merica, R., Jenkins, M. K. & Hodes, R. Cutting edge: antigen-dependent regulation of telomerase activity in murine T cells. J. Immunol. 160, 5702-5705 (1998).
124. Morrison, S. J., Prowse, K. R., Ho, P. & Weissman, I. L. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5, 207-216 (1996).
125. Voehringer, D. et al. Viral infections induce abundant numbers of senescent CD8 T cells. J. Immunol. 167, 4838-4843 (2001).
126. + T cells become nonresponsive (anergic) following activation in the presence of costimulation. J. Immunol. 163, 102-110 (1999).
127. Bikah, G., Pogue-Caley, R. R., McHeyzer-Williams, L. J. & McHeyzer-Williams, M. G. Regulating T-helper-cell immunity through antigen responsiveness and calcium entry. Nature Immunol. 1, 402-412 (2000).
128. Sigal, L. J., Reiser, H. & Rock, K. L. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo. J. Immunol. 161, 2740-2745 (1998).
129. Lumsden, J. M., Roberts, J. M., Harris, N. L., Peach, R. J. & Ronchese, F. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection. J. Immunol. 164, 79-85 (2000).
130. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R. & Melief, C. J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480-483 (1998).
131. + T-cell responses. Curr. Biol. 4, 499-505 (1994).
132. + T-helper and a T-killer cell Nature 393, 474-478 (1998).
133. Geiselhart, L. A. et al. IL-7 administration alters the CD4:CD8 ratio, increases T-cell numbers, and increases T-cell function in the absence of activation. J. Immunol. 166, 3019-3027 (2001).
134. Kennedy, M. K. et al. Reversible defects in natural killer and memory CD8 T-cell lineages in interleukin-15-deficient mice. J. Exp. Med. 191, 771-780 (2000).
135. Ahlers, J. D., Belyakov, I. M., Matsui, S. & Berzofsky, J. A. Mechanisms of cytokine synergy essential for vaccine protection against viral challenge. Int. Immunol. 13, 897-908 (2001).
136. Khatami, S., Brummer, E. & Stevens, D. A. Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in vivo on cytokine production and proliferation by spleen cells. Clin. Exp. Immunol. 125, 198-201 (2001).